Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106–01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
The effect of four different neuropeptides and norepinephrine (NE) on cyclic AMP formation in four different osteoblastic cell lines and in isolated neonatal mouse calvarial bone cells has been examined. In the rat osteosarcoma cell line UMR-106–01, vasoactive intestinal polypeptide (VIP, 0.001–1 μM), calcitonin gene-related peptide (CGRP, 0.3–30 nM), and NE (0.1–300 μM), but not neuropeptide Y (NPY, 0.001–1 μM) or substance P (SP, 0.1–10 μM), caused a dose-dependent stimulation of cyclic AMP formation. The stimulatory effects were synergistically potentiated by forskolin (0.1–3 μM). The effects of NE and VIP were time dependent, with an optimal effect seen at 5 minutes. The amount of cyclic AMP accumulated in cells stimulated with NE and VIP was in the same range. The amplitude of the cyclic AMP response induced by CGRP was smaller than that caused by VIP and NE. In the human osteosarcoma cell line Saos-2, NE (0.1 μM) and VIP (0.3 μM) stimulated cyclic AMP formation, and the effect was synergistically potentiated by forskolin. In the absence of forskolin, no effect of CGRP (30 nM) could be seen in the Saos-2 cells, but in the presence of forskolin (3 μM) a stimulatory effect was observed. SP and NPY did not change basal cyclic AMP levels in Saos-2 cells. In the osteoblastic osteosarcoma cell line of rat, ROS 17/2.8, NE (0.1 μM) caused a significant stimulatory action on cyclic AMP formation that was synergistically potentiated by forskolin (3 μM), VIP, CGRP, and SP did not affect the cellular content of cyclic AMP in ROS 17/2.8. In the mouse calvarial cell line MC3T3-E1 and in enzymatically isolated mouse calvarial bone cells, NE (0.1 μM), VIP (0.3 μM), and CGRP (30 nM), but not SP (10 μM) or NPY (1 μM), stimulated cyclic AMP formation. In UMR-106–01 cells and in isolated bone cells, but not in Saos-2 and ROS 17/2.8 cells, NPY (1 μM) inhibited the stimulatory effect of NE (0.3 μM) on cyclic AMP formation. These data show that osteoblastic cell lines are equipped with receptors for neuropeptides and NE. Since VIP, CGRP, NPY, and NE have been shown to occur in nerves of the skeleton, the observations in the present paper suggest the possibility that neurohormones may have a role in the regulation of osteoblastic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CGRP treatment increased cAMP levels in the UMR 106-01 rat osteosarcoma cell line and in other osteoblastic cell lines and primary osteoblast cultures (18,148,200).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [18]
Citations
Cites
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.1.191 · Cited by 1,671
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.
Rodan, S. B., Imai, Y., Thiede, M. A., Wesolowski, G. A., Thompson, D., Bar‐Shavit, Z., Shull, S., Mann, K. G., & Rodan, G. A. (1987) · PubMed · Cited by 680
Gibbins, I. L., Furness, J. B., Costa, M., MacIntyre, I., Hillyard, C. J., & Girgis, S. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90050-3 · Cited by 633
Wiesenfeld-Hallin, Z., Hökfelt, T., Lundberg, J. M., Forssmann, W. G., Reinecke, M., Tschopp, F. A., & Fischer, J. A. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90374-4 · Cited by 579
Premakumari, S. (1986) · The Indian Journal of Nutrition and Dietetics · Cited by 577
Parathyroid Hormone-Responsive Clonal Cell Lines from Rat Osteosarcoma*
MAJESKA, R. J., RODAN, S. B., & RODAN, G. A. (1980) · Endocrinology · doi:10.1210/endo-107-5-1494 · Cited by 473
VAES, G. (1988) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198806000-00033 · Cited by 404
Substance P- and CGRP-immunoreactive nerves in bone
Bjurholm, A., Kreicbergs, A., Brodin, E., & Schultzberg, M. (1988) · Peptides · doi:10.1016/0196-9781(88)90023-x · Cited by 386
Self-citationPartridge, N. C., Alcorn, D., Michelangeli, V. P., Ryan, G. B., & Martin, T. J. (1983) · PubMed · Cited by 310
Research works printed but not linked: 5
- Boonekamp, 1984, Effect of culture on the hormone responsiveness of bone cells isolated by an improved sequential digestion procedure, Proc Kon Ned Akad Wet, B87, 371
- Rahman, 1989, The effect of neuropeptides in connective tissue metabolism (abstract)?, J Bone Miner Res, 4, S409
- Lerner, 1989, Helo-dermin coexists with calcitonin in thyroid C cells, decreases calcium incorporation and increases cyclic AMP formation in bone (abstract), J Bone Miner Res, 4, S340
- Crawford, 1985, Effect of human calcitonin gene-related peptide on human bone-derived cells in culture (abstract), Bone, 7, 156
- Hill, 1989, Changes in induced bone remodeling in sympathectomized and sensory denervated rats (abstract), J Bone Miner Res, 4, S382
Cited by
Serre, C. M., Farlay, D., Delmas, P. D., & Chenu, C. (1999) · Bone · doi:10.1016/s8756-3282(99)00215-x · Cited by 261
Glutamate Receptors Are Expressed by Bone Cells and Are Involved in Bone Resorption
Chenu, C., Serre, C. M., Raynal, C., Burt-Pichat, B., & Delmas, P. D. (1998) · Bone · doi:10.1016/s8756-3282(97)00295-0 · Cited by 239
Regulation of bone remodeling by the central and peripheral nervous system
Elefteriou, F. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.016 · Cited by 229
Togari, A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10121 · Cited by 213
“These findings agree with the pharmacological responses previously reported to occur in osteoblastic cells (Bjurholm, 1991; Bjurholm et al., 1988a, 1992; Hohmann and Tashjian, 1984; Michelangeli et al., 1986; Moore et al., 1993).”
ResultThe effect of diabetes mellitus on osseous healing
Retzepi, M., & Donos, N. (2010) · Clinical Oral Implants Research · doi:10.1111/j.1600-0501.2010.01923.x · Cited by 201
Togari, A., Arai, M., Mizutani, S., Mizutani, S., Koshihara, Y., & Nagatsu, T. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00649-6 · Cited by 210
Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis
Baldock, P. A., Allison, S. J., Lundberg, P., Lee, N. J., Slack, K., Lin, E.-J. D., Enriquez, R. F., McDonald, M. M., Zhang, L., During, M. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700644200 · Cited by 202
Neuropeptides in Dental Pulp: The Silent Protagonists
CAVIEDESBUCHELI, J., MUNOZ, H., AZUEROHOLGUIN, M., & ULATE, E. (2008) · Journal of Endodontics · doi:10.1016/j.joen.2008.03.010 · Cited by 180
Wang, L., Zhao, R., Shi, X., Wei, T., Halloran, B. P., Clark, D. J., Jacobs, C. R., & Kingery, W. S. (2009) · Bone · doi:10.1016/j.bone.2009.04.203 · Cited by 179
“Paradoxically, SP inhibitory effects have been observed on alkaline phosphatase activity, mineralization, and osteoblastic gene expression, and in addition, SP had no effect on cAMP production in osteoblastic cell lines and in mouse calvarial osteoblastic cells [15–17].”
BackgroundCapsaicin-Sensitive Sensory Neurons Contribute to the Maintenance of Trabecular Bone Integrity
Offley, S. C., Guo, T.-Z., Wei, T., Clark, J. D., Vogel, H., Lindsey, D. P., Jacobs, C. R., Yao, W., Lane, N. E., & Kingery, W. S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041108 · Cited by 175
Imai, S., & Matsusue, Y. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10119 · Cited by 150
Cherruau, M., Facchinetti, P., Baroukh, B., & Jl, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00211-2 · Cited by 147
Lundberg, P., Allison, S. J., Lee, N. J., Baldock, P. A., Brouard, N., Rost, S., Enriquez, R. F., Sainsbury, A., Lamghari, M., Simmons, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609629200 · Cited by 144
N europeptides and N eurogenic M echanisms in O ral and P eriodontal I nflammation
Lundy, F. T., & Linden, G. J. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500203 · Cited by 189
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“CGRP treatment increased cAMP levels in the UMR 106-01 rat osteosarcoma cell line and in other osteoblastic cell lines and primary osteoblast cultures (18, 148, 200).”
BackgroundIrie, K., Hara‐Irie, F., Ozawa, H., & Yajima, T. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10122 · Cited by 135
“An increase of cyclic AMP by CGRP, as well as CGRP binding, have been demonstrated both in a transformed osteoblastic cell line and in primary osteoblasts from calvariae (Bjurholm et al., 1992; Michelangeli et al., 1986, 1989; Tamura et al., 1992).”
BackgroundNeuropeptides and the puzzle of bone remodeling: State of the art
Konttinen, Y. T., Imai, S., & Suda, A. (1996) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679608997772 · Cited by 148
Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology
Grässel, S., & Muschter, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050931 · Cited by 130
“8, the human osteosarcoma cell line Saos-2, a mouse calvarial pre-osteoblastic cell line, MC3T3-E1, and in primary mouse neonatal calvarial bone cells, indicating a minor role for SP in osteoblast function regulation [85].”
BackgroundBone and brain: a review of neural, hormonal, and musculoskeletal connections.
Jones, K. B., Mollano, A. V., Morcuende, J. A., Cooper, R. R., & Saltzman, C. L. (2004) · Europe PMC (PubMed Central) · Cited by 136
Hara‐Irie, F., Amizuka, N., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00425-4 · Cited by 123
Lee, N. J., Doyle, K. L., Sainsbury, A., Enriquez, R. F., Hort, Y. J., Riepler, S. J., Baldock, P. A., & Herzog, H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.61 · Cited by 113
Fracture Healing and Callus Innervation After Peripheral Nerve Resection in Rats
Madsen, J. E., Hukkanen, M., Aune, A. K., Basran, I., Moller, J. F., Polak, J. M., & Nordsletten, L. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199806000-00028 · Cited by 118
Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors
Goto, T., Nakao, K., Gunjigake, K. K., Kido, M. A., Kobayashi, S., & Tanaka, T. (2007) · Neuropeptides · doi:10.1016/j.npep.2006.11.002 · Cited by 105
“CGRP enhances cyclic AMP production by chicken, mouse, and rat osteoblastic cells (Michelangeli et al., 1989; Bjurholm et al., 1992).”
Bone Reinnervation After Fracture: A Study in the Rat
Li, J., Ahmad, T., Spetea, M., Ahmed, M., & Andris Kreicbergs, A. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1505 · Cited by 97
Lerner, U. H., & Persson, E. (2008) · PubMed · Cited by 116
Suzuki, A., Palmer, G., Bonjour, J. ‐., & Caverzasio, J. (1998) · Bone · doi:10.1016/s8756-3282(98)00099-4 · Cited by 93
Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue
Shi, Y., & Baldock, P. A. J. (2011) · Bone · doi:10.1016/j.bone.2011.10.001 · Cited by 101
“NPY treatment to osteoblastic cells in vitro inhibits the cyclic AMP response to parathyroid hormone, norepinephrine and forskolin [52,56,57].”
BackgroundFristad, I., Heyeraas, K. J., & Kvinnsland, I. H. (1994) · Archives of Oral Biology · doi:10.1016/0003-9969(94)90089-2 · Cited by 89
Lundberg, P., Lie, A., Bjurholm, A., Lehenkari, P. P., Horton, M. A., Lerner, U. H., & Ransjö, M. (2000) · Bone · doi:10.1016/s8756-3282(00)00394-x · Cited by 88
Self-citationImai, S., Tokunaga, Y., Maeda, T., Kikkawa, M., & Hukuda, S. (1997) · Journal of Orthopaedic Research · doi:10.1002/jor.1100150120 · Cited by 88
Topical application of nerve growth factor improves fracture healing in rats
Grills, B. L., Schuijers, J. A., & Ward, A. R. (1997) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100150212 · Cited by 85
Mukohyama, H., Ransjö, M., Taniguchi, H., Ohyama, T., & Lerner, U. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2599 · Cited by 90
Lundberg, P., Lundgren, I., Mukohyama, H., Lehenkari, P. P., Horton, M. A., & Lerner, U. H. (2001) · Endocrinology · doi:10.1210/endo.142.1.7912 · Cited by 85
“the rat osteosarcoma cell line UMR 106–01 (21, 22), in a”
BackgroundInfluentialNPY regulation of bone remodelling
Lee, N. J., & Herzog, H. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.08.006 · Cited by 86
Drissi, H., Lasmoles, F., Mellay, V. L., Marie, P. J., & Lieberherr, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20168 · Cited by 91
Cherruau, M., Morvan, F., SCHIRAR, A., & Jl, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10209 · Cited by 85
“Indeed, osteoblasts bear functional receptors for VIP (Bjurholm et al., 1992; Lundberg et al., 2001).”
BackgroundCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Neuropeptidergic regulation of bone resorption and bone formation.
Lerner, U. H. (2002) · PubMed · Cited by 85
The development of autonomic innervation in bone and joints of the rat
Sisask, G., Bjurholm, A., Ahmed, M., & Andris Kreicbergs, A. (1996) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(95)00139-5 · Cited by 67
Self-citationAkopian, A., Demulder, A., Ouriaghli, F. E., Corazza, F., Fondu, P., & Bergmann, P. (2000) · Peptides · doi:10.1016/s0196-9781(00)00185-6 · Cited by 68
High Expression of Neuropeptide Y1 Receptors in Ewing Sarcoma Tumors
Körner, M., Waser, B., & Reubi, J. C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4551 · Cited by 71
Active NMDA glutamate receptors are expressed by mammalian osteoclasts
Espinosa, L., Itzstein, C., Cheynel, H., Delmas, P. D., & Chenu, C. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0047r.x · Cited by 66
Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 61
Franquinho, F., Liz, M. A., Nunes, A. F., Neto, E., Lamghari, M., & Sousa, M. M. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07774.x · Cited by 63
Ontogeny of sensory and autonomic nerves in the developing mouse skeleton
Sisask, G., Silfverswärd, C.-J., Bjurholm, A., & Nilsson, O. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.05.005 · Cited by 61
Self-citationExtraction and quantitation of neuropeptides in bone by radioimmunoassay
Ahmed, M., Srinivasan, G. R., Theodorsson, E., Bjurholm, A., & Kreicbergs, A. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90063-9 · Cited by 61
Self-citationEyre, L. J., Rabbitt, E. H., Bland, R., Hughes, S. V., Cooper, M. S., Sheppard, M. C., Stewart, P. M., & Hewison, M. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010601)81:3<453::aid-jcb1059>3.0.co;2-z · Cited by 35
A mechanism for sympathectomy-induced bone resorption in the middle ear
SHERMAN, B., & Chole, R. A. (1995) · Otolaryngology · doi:10.1016/s0194-5998(95)70048-x · Cited by 57
Imai, S., Rauvala, H., Konttinen, Y. T., Tokunaga, T., Maeda, T., Hukuda, S., & Santavirta, S. S. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1018 · Cited by 54
Substance P and its receptors in bone metabolism
Liu, D., Jiang, L., & Dai, L. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.05.003 · Cited by 55
Neuro-hormonal control of bone metabolism:
Lundberg, P., Boström, I. M., Mukohyama, H., Bjurholm, A., Smans, K. A., & Lerner, U. H. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00069-5 · Cited by 51
Self-citationInhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells
AMANO, S., ARAI, M., GOTO, S., & Togari, A. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.02.009 · Cited by 54
Emerging neuroskeletal signalling pathways: a review
Spencer, G. J., Hitchcock, I. S., & Genever, P. G. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00053-5 · Cited by 54
Different sympathetic pathways control the metabolism of distinct bone envelopes
Bataille, C., Mauprivez, C., Haÿ, E., Baroukh, B., Brun, A., Chaussain, C., Marie, P. J., Jl, S., & Cherruau, M. (2012) · Bone · doi:10.1016/j.bone.2012.01.023 · Cited by 53
“For instance, although in vitro osteoblasts from long bones and calvaria express a large repertoire of receptors for neuropeptides and neurotransmitters [3,9,20,47,48], their expression is probably restricted in vivo.”
BackgroundSkeletal changes in type-2 diabetic Goto-Kakizaki rats
Ahmad, T., Ohlsson, C., Sääf, M., Östenson, C.-G., & Andris Kreicbergs, A. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780111 · Cited by 47
“Neuropathy may also have direct effects on bone through neurotransmitter action on bone cells (Bjurholm et al. 1992, Lerner 2002).”
BackgroundOntogeny of sensory nerves in the developing skeleton
Sisask, G., Bjurholm, A., Ahmed, M., & Andris Kreicbergs, A. (1995) · The Anatomical Record · doi:10.1002/ar.1092430210 · Cited by 46
Self-citationFristad, I., Vandevska‐Radunovic, V., Fjeld, K., Wimalawansa, S. J., & Kvinnsland, I. H. (2003) · Cell and Tissue Research · doi:10.1007/s00441-002-0691-z · Cited by 48
“In vitro studies (Mitsuhashi and Payan 1987; Bernard and Shih 1990; Haegerstrand et al. 1990; Bjurholm et al. 1992) have given indications that the neuropeptides SP and CGRP act as growth factors by stimulating cell proliferation and activation of intracellular signaling mechanisms.”
BackgroundNeuropeptide Y innervation during fracture healing and remodeling
Long, H., Ahmed, M., Ackermann, P. W., Stark, A., & Li, J. (2010) · Acta Orthopaedica · doi:10.3109/17453674.2010.504609 · Cited by 43
“The morphological changes representing callus thickness between the concave and convex sides were based on observations in 4 rats at each time point (Figure 2A and F).”
BackgroundStein, M., Elefteriou, F., Busse, B., Fiedler, I. A., Kwon, R. Y., Farrell, E., Ahmad, M., Ignatius, A., Grover, L., Geris, L., et al. (2023) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4868 · Cited by 42
“Calvarial pre-osteoblast cells, stromal mesenchymal cells from bone marrow, and outgrowths from human bone specimens can be utilized to recapitulate osteoblast differentiation.((27-31)) Osteoclasts can be derived from peripheral blood monocytes or bone marrow of rodents, birds (mainly chickens), and rabbits to allow o…”
BackgroundDrissi, H., Hott, M., Marie, P. J., & Lasmoles, F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1805 · Cited by 42
“The presence of receptors for CGRP in osteoblastic cells was suggested by the stimulatory effect of CGRP on cAMP levels in osteoblast-rich populations from chick, rat, and mouse calvaria,((27,28)) in MC3T3-E1 cells,((28)) in murine preosteoblastic KS-4 cells,((29)) in rat UMR 106-01,((4,28,30)) and in Saos-2 and TE85…”
BackgroundDental Innervation: Functions and Plasticity After Peripheral Injury
Fristad, I. (1997) · Acta Odontologica Scandinavica · doi:10.3109/00016359709115423 · Cited by 44
Ma, W., Zhang, X., Shushan, S., & Zhang, Y. (2013) · Neuropeptides · doi:10.1016/j.npep.2012.12.002 · Cited by 41
A Novel Role of the Sympatho-Adrenergic System in Regulating Valve Calcification
Osman, L., Chester, A. H., Sarathchandra, P., Latif, N., Meng, W., Taylor, P. M., & Yacoub, M. H. (2007) · Circulation · doi:10.1161/circulationaha.106.681072 · Cited by 38
Asmus, S. E., Tian, H., & Landis, S. C. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0282 · Cited by 36
Neuronal Control of Bone Remodeling
Corr, A., Smith, J., & Baldock, P. (2017) · Toxicologic Pathology · doi:10.1177/0192623317738708 · Cited by 35
“The presence of Y receptors has also been demonstrated, and a reduced response to parathyroid hormone and noradrenaline in osteoblastic cells following NPY treatment again indicating a regulatory function in bone for NPY (Bjurholm 1991; Bjurholm et al. 1992).”
BackgroundThe control of bone remodeling by neuropeptide Y receptors
Allison, S. J., Baldock, P. A. J., & Herzog, H. (2006) · Peptides · doi:10.1016/j.peptides.2006.05.029 · Cited by 44
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy
Petrova, N. L., & Shanahan, C. M. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2511-6 · Cited by 31
“CGRP increases osteoblastic cyclic adenosine monophosphate via acting on bone specific CGRP receptors [71] thus stimulating osteogenesis [72].”
BackgroundThe NPY System and its Neural and Neuroendocrine Regulation of Bone
Khor, E. C., & Baldock, P. A. J. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0102-7 · Cited by 39
Obata, K., Furuno, T., Nakanishi, M., & Togari, A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.065 · Cited by 31
“bone cells [27] and that NA, VIP, and ATP transiently increased the intracellular Ca level in a rat osteoblast-like osteosarcoma cell line, UMR-106 [28].”
BackgroundJacobsen, E. B., & Heyeraas, K. J. (1996) · Archives of Oral Biology · doi:10.1016/s0003-9969(96)00092-1 · Cited by 32
Neuronal control of bone and muscle
Houweling, P. J., Kulkarni, R. N., & Baldock, P. A. J. (2015) · Bone · doi:10.1016/j.bone.2015.05.006 · Cited by 30
“Very early studies demonstrated that NPY treatment in osteoblastic cell lines inhibited the cAMP response to parathyroid hormone andnorepinephrine [18,19], suggesting the presence of functional Y receptors on bone cells and a possible regulatory role for NPY in the bone.”
BackgroundMurakami, K., Nakagawa, H., Nishimura, K., & Matsuo, S. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0446 · Cited by 33
Central regulation of bone mass
Wong, I. P. L., Zengin, A., Herzog, H., & Baldock, P. A. J. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.08.001 · Cited by 34
Lerner, U. H., Lundberg, P., Ransj�, M., Persson, P., & H�kanson, R. (1994) · Calcified Tissue International · doi:10.1007/bf00295952 · Cited by 30
“A 5-minute incubation was used as we have previously found that the effect of parathyroid hormone (PTH) on cAMP formation in mouse calvarial osteoblast-like cells is optimal at this time point and that VIP causes a cAMP response in UMR 106-01 cells which is optimal at 5 minutes [14].”
MethodKinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Burns, D. M., Stehno‐Bittel, L., & Kawase, T. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00274.2003 · Cited by 32
“01% trifluoroacetic acid) alone was added demonstrated that no more than a 2–3% decline in DiBAC4(3) fluorescent emission normally occurs over 900 s of low-level laser illumination.”
BackgroundMethodInfluentialThai, J., Fuller‐Jackson, J., & Ivanusic, J. J. (2024) · The Journal of Comparative Neurology · doi:10.1002/cne.25582 · Cited by 37
The Enkephalinergic Osteoblast
Rosen, H., Krichevsky, A., & Bar-Shavit, Z. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1515 · Cited by 28
“related peptide, substance P, neuropeptide Y, and norepinephrine (NE) in osseal nerve fibers.((4,5)) The abundance of”
BackgroundNaviglio, S., Spina, A., Chiosi, E., Fusco, A., Illiano, F., Pagano, M., Romano, M., Senatore, G., Sorrentino, A., Sorvillo, L., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20892 · Cited by 31
“However, in human osteosarcoma cells epinephrine and norepinephrine have been described to increase intracellular levels of cAMP [Bjurholm et al., 1992; Moore et al., 1993].”
BackgroundKawase, T., Okuda, K., & Burns, D. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01763-1 · Cited by 29
Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells
Lundberg, P., & Lerner, U. H. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10124 · Cited by 31
“In addition, VIP has been found to stimulate cyclic AMP formation in isolated mouse calvarial osteoblasts and in the cloned, non-transformed, osteoblastic cell line MC3T3-E1 (Bjurholm et al., 1992; Lerner et al., 1994).”
BackgroundInfluentialInflammatory nerve responses in the dental pulp
Fristad, I., Bletsa, A., & Byers, M. R. (2007) · Endodontic Topics · doi:10.1111/j.1601-1546.2010.00247.x · Cited by 29
Catecholamines modulate growth and differentiation of human preosteoclastic cells
Frediani, U., Becherini, L., Lasagni, L., Tanini, A., & Brandi, M. L. (1996) · Osteoporosis International · doi:10.1007/bf01626532 · Cited by 27
“Several pieces of evidence exist regarding the presence of catecholamine receptors linked to cAMP formation in osteoblast-like cells such as UMR-106-01 [9], ROS 17/2.”
BackgroundInfluentialNeural involvement in post-traumatic osteopenia: An experimental study in the rat
Madsen, J. E., Aune, A. K., Falch, J. A., Hukkanen, M., Konttinen, Y. T., Santavirta, S. S., & Nordsletten, L. (1996) · Bone · doi:10.1016/8756-3282(96)00027-0 · Cited by 27
Kawase, T., & Burns, D. M. (1998) · Endocrinology · doi:10.1210/endo.139.8.6151 · Cited by 30
The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts
Persson, E., & Lerner, U. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23304 · Cited by 31
“These observations indicate that SaOS-2 and MG63 express functional VIP receptors, in line with our previous observations using cyclic AMP as a parameter of VIP receptor function [Bjurholm et al., 1992].”
BackgroundMethodResultInfluentialSensory nerve ingrowth during bone graft incorporation in the rat
Madsen, J. E., Wang, J., Hukkanen, M., Nordsletten, L., Konttinen, Y. T., Santavirta, S. S., Polak, J. M., & Aspenberg, P. (1996) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679608994676 · Cited by 26
Yu, W. H., Chen, F., Xu, W., Ding, S., Chen, P., Yang, L., Jiang, S., & Pan, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.583105 · Cited by 23
“In osteoblastic cells, NPY is reported to reduce cAMP production and inhibit osteoblast differentiation (22, 23).”
BackgroundAzevedo, M. D. C. S., Fonseca, A. C., Colavite, P. M., Melchiades, J. L., Tabanêz, A. P., Codo, A. C., de Medeiros, A. I., Trombone, A. P. F., & Garlet, G. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.782566 · Cited by 29
Uemura, T., Ohta, Y., Nakao, Y., Manaka, T., Nakamura, H., & Takaoka, K. (2010) · Bone · doi:10.1016/j.bone.2010.07.008 · Cited by 23
“As expected from previous classical reports, epinephrine addition to osteogenic cells instantly elevated the intra-cellular cAMP level [10–14].”
BackgroundSuzuki, A., Kotoyori, J., Oiso, Y., & Kaozawa, O. (1994) · Cellular Signalling · doi:10.1016/0898-6568(94)90056-6 · Cited by 23
Gajda, M., Litwin, J. A., Tabarowski, Z., Zagólski, O., Cichocki, T., Timmermans, J., & Adriaensen, D. (2010) · Cells Tissues Organs · doi:10.1159/000276591 · Cited by 22
“The effect of autonomic neurotransmitters [noradrenaline, neuropeptide Y (NPY), VIP] on bone cells was confirmed by in vitro studies and denervation experiments [Bjurholm et al., 1992; Cherruau et al., 1999; Hill et al., 1991; Lundberg et al., 2000].”
BackgroundTransient local presence of nerve fibers at onset of secondary ossification in the rat knee joint
Hedberg, A., Messner, K., Persliden, J., & Hildebrand, C. (1995) · Anatomy and Embryology · doi:10.1007/bf00184749 · Cited by 23
Nohutçu, R. M., McCauley, L. K., Horton, J. E., Capen, C. C., & Rosol, T. J. (1993) · Archives of Oral Biology · doi:10.1016/0003-9969(93)90096-5 · Cited by 22
Central Neuronal Control of Bone Remodeling
Ochi, H., Baldock, P. A. J., & Takeda, S. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch131 · Cited by 22
Time-dependent sensory nerve ingrowth into a bone conduction chamber
Madsen, J. E., Hukkanen, M., Aspenberg, P., Polak, J. M., & Nordsletten, L. (2000) · Acta Orthopaedica Scandinavica · doi:10.1080/00016470052943946 · Cited by 21
“Further, it impairs bone resorption by inhibiting osteoclast activity and recruitment (D’Souza et al. 1986, Zaidi et al. 1987, Hara-Irie et al. 1996), and osteogenesis is stimulated by direct receptor effects on osteoblasts (Bernard and Shih 1990, Bjurholm et al. 1992).”
BackgroundThe neuro-osteogenic network: The sympathetic regulation of bone resorption
Togari, A., Arai, M., Kondo, H., Kodama, D., & Niwa, Y. (2012) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2011.12.002 · Cited by 23
“Indeed, NPY inhibited the stimulatory effect of NA on cAMP in UMR-106-01 cells and isolated bone cells [65].”
BackgroundBone and joint neuropathy in rats with type-2 diabetes
Ahmad, T., Ugarph-Morawski, A., Li, J., Bilevičiūtė-Ljungar, I., Finn, A., Östenson, C., & Kreicbergs, A. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.12.008 · Cited by 22
The Multifactorial Role of Peripheral Nervous System in Bone Growth
Gkiatas, I. S., Papadopoulos, D., Pakos, E. E., Kostas‐Agnantis, I., Gelalis, I. D., Vekris, M. D., & Korompilias, A. V. (2017) · Frontiers in Physics · doi:10.3389/fphy.2017.00044 · Cited by 18
“The role of SP is the stimulation of cAMP production by osteoblastic cells [25].”
BackgroundWang, X.-Y., Guo, X., Qu, S. X., Weng, J., & Cheng, C.-Y. J. (2009) · Spine · doi:10.1097/brs.0b013e3181b04e52 · Cited by 16
“This finding suggested that the CGRP-positive fibers regulated the differentiation of chondrocytes from mesenchymal cells in rhBMP-4 induced ectopic osteogenesis while it was considered to regulate proliferation of osteoblasts in fracture healing.(7,20,23,25,28) An interesting finding of the present study was that the…”
Background
Metadata
- Authors
- Bjurholm, A., Kreicbergs, A., Schultzberg, M., & Dr. Lerner, U. H.
- Affiliations
- Karolinska University Hospital (SE)
- Department of Orthopaedic Surgery, Karolinska Hospital, Stockholm, Sweden
- Karolinska Institutet (SE)
- Department of Oral Cell Biology, University of Umeå, Sweden
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-09-01
- Volume
- 7
- Issue
- 9
- Pages
- 1011-1019
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2046737969
- Semantic Scholar
- 97bfd7dae8469ee3deed64a3bbd93d6dbe59fb22
- Cited by
- 145
- References
- 31
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 6 · 2015: 3 · 2013: 6 · 2012: 5
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swedish Medical Research Council ((07525, 08652))
- Magnus Bergvall Foundation
- Swedish Association Against Rheumatic Diseases
- Royal 80 Year Fund of King Gustav V, and Svenska Sallskapet for Medicinsk Forskning
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- cyclic AMP, osteoblasts, neuropeptides, norepinephrine, vasoactive intestinal peptide, calcitonin gene-related peptide, substance P, neuropeptide Y, forskolin, synergistic stimulation, Saos-2 cells
- MeSH terms
- Cyclic AMP, Animals, Cell Line, Cells, Cultured, Colforsin, Neuropeptide Y, Neuropeptides, Norepinephrine, Osteoblasts, Osteosarcoma, Substance P, Tumor Cells, Cultured, Vasoactive Intestinal Peptide, Calcitonin Gene-Related Peptide, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.